RESEARCH BLOG Blogs

March 12, 2025

Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation

Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts

READ MORE about Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation›
January 28, 2025

Real-World Examples of Patient Involvement in Designing Clinical Trials

Read time: 2 minutes. Here we present the final video in our three-part series about how patients and researchers can work together to develop clinical trials. In the video below

READ MORE about Real-World Examples of Patient Involvement in Designing Clinical Trials›
January 21, 2025

Developing Clinical Trials that Account for the Realities of Patient Life

Read time: 2 minutes. We are pleased to continue our three-part series about how patients and researchers can work together to develop clinical trials. In this second video

READ MORE about Developing Clinical Trials that Account for the Realities of Patient Life›
December 10, 2024

Research Milestones: Celebrating LUNGevity’s 2024 Research Awards

LUNGevity had a tremendous year supporting impactful research in 2024. In addition to our existing portfolio of ongoing research grants, we issued several new research awards in

READ MORE about Research Milestones: Celebrating LUNGevity’s 2024 Research Awards›
November 19, 2024

Celebrating 20 Years of Progress in Lung Cancer Research and Treatment

Read time: 5 minutes. This year marks 20 years since researchers made a key discovery that changed the face of lung cancer research and treatment. By uncovering EGFR’s role in lung

READ MORE about Celebrating 20 Years of Progress in Lung Cancer Research and Treatment›
November 12, 2024

Bringing the Underserved LGBTQIA2S+ Community into the Lung Cancer Spotlight

How can you help the people you can’t see? For most people the answer is: You can’t. Matty Triplette’s approach is different: Get a flashlight if you have to. Find a way to see

READ MORE about Bringing the Underserved LGBTQIA2S+ Community into the Lung Cancer Spotlight›
October 10, 2024

Screening and Early Detection of Lung Cancer: Highlights from WCLC and ESMO 2024

Lung cancer screening and early detection were major topics of discussion at the World Conference on Lung Cancer (WCLC), held in San Diego from September 7-10, and the European

READ MORE about Screening and Early Detection of Lung Cancer: Highlights from WCLC and ESMO 2024›
October 07, 2024

Early-Stage and Locally Advanced Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

This is the third recap blog in our series of updates from the World Conference on Lung Cancer (WCLC), held in San Diego from September 7-10, and the European Society for Medical

READ MORE about Early-Stage and Locally Advanced Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024›
October 03, 2024

Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

This is the second blog in our series of updates from the World Conference on Lung Cancer (WCLC), held in San Diego from September 7-10, and the European Society for Medical

READ MORE about Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024›
October 01, 2024

Metastatic Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

This year, the first three weeks of September were packed with lung cancer research updates at the World Conference on Lung Cancer (WCLC) from September 7-10 in San Diego followed

READ MORE about Metastatic Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024›
August 27, 2024

How Do Drugs Get Approved (and Fast-Tracked) by the FDA?

Read time: 5 minutes. This is Part 3 in our series on how drugs get approved to treat lung cancer. Part 1: Understanding Clinical Trials - Why Are They Important for Drug

READ MORE about How Do Drugs Get Approved (and Fast-Tracked) by the FDA?›
August 20, 2024

How We Define Success for a Clinical Trial

Read time: 6 minutes. This is Part 2 of 3 in our series on how drugs get approved to treat lung cancer. Make sure to read Part 1 on the phases of clinical trials and why they are

READ MORE about How We Define Success for a Clinical Trial›

RESEARCH BLOG Blogs

Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation

Real-World Examples of Patient Involvement in Designing Clinical Trials

Developing Clinical Trials that Account for the Realities of Patient Life

Research Milestones: Celebrating LUNGevity’s 2024 Research Awards

Celebrating 20 Years of Progress in Lung Cancer Research and Treatment

Bringing the Underserved LGBTQIA2S+ Community into the Lung Cancer Spotlight

Screening and Early Detection of Lung Cancer: Highlights from WCLC and ESMO 2024

Early-Stage and Locally Advanced Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

Metastatic Non-Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024

How Do Drugs Get Approved (and Fast-Tracked) by the FDA?

How We Define Success for a Clinical Trial

LUNGevity Foundation

CHICAGO OFFICE

BETHESDA OFFICE

MAILING ADDRESS